0000899243-20-033475.txt : 20201211 0000899243-20-033475.hdr.sgml : 20201211 20201211061643 ACCESSION NUMBER: 0000899243-20-033475 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baeuerle Patrick CENTRAL INDEX KEY: 0001362054 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38811 FILM NUMBER: 201382205 MAIL ADDRESS: STREET 1: WOLDPROMENADE 18C CITY: GAUTING STATE: 2M ZIP: 82131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC. CENTRAL INDEX KEY: 0001750019 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474152751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-5200 MAIL ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-10 0 0001750019 TCR2 THERAPEUTICS INC. TCRR 0001362054 Baeuerle Patrick TCR2 THERAPEUTICS INC. 100 BINNEY STREET CAMBRIDGE MA 02142 1 0 0 0 Common Stock 350786 I By APAK Solutions GmbH Stock Option (Right to Buy) 31.83 2020-12-10 4 A 0 12100 0.00 A 2030-12-09 Common Stock 12100 12100 D The reported securities are owned directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. 25% of this option shall vest and become exercisable on January 1, 2022, with the remainder vesting in twenty-four (24) equal monthly installments thereafter. /s/ Margaret Siegel as Attorney-in-Fact 2020-12-10